For more than 20 years, I've dedicated my career at UCLA to combating digestive diseases like IBD, C. difficile, and obesity. My research leverages cutting-edge multiomics analysis, high-throughput drug screening, and machine learning to identify key biomarkers and therapeutic targets – proteins, miRNAs, and chemicals. This has led to the development of new treatments and a deeper understanding of these diseases. Supported by NIH grants and industry collaborations with companies like Merck, my lab has published many manuscripts and secured multiple US patents, contributing to FDA-approved therapies. We're equipped with state-of-the-art facilities, and I'm passionate about mentoring future scientists. My interdisciplinary approach allows me to translate findings across diseases, driving impactful research and ultimately improving patient outcomes.